"The Surprising Anti-Aging Benefits of a Transplant Drug"

Rapamycin, a drug initially approved for transplant patients, has gained popularity as an anti-aging treatment despite lacking evidence of extending human life. The drug's potential stems from animal studies showing benefits in longevity, but its use remains divisive among scientists and practitioners due to potential side effects and lack of optimal dosing for humans. Despite regulatory limitations, more medical practices are prescribing rapamycin for anti-aging, and telehealth companies are making it available to thousands of patients. The drug's rise parallels the growing field of longevity medicine, with some influential figures advocating for its use while others caution against substituting it for a healthy lifestyle.